Virtual COVID-19 Conference on breaking COVID-19 research, policy analysis and frontline experience on the final day of AIDS 2020 : Virtual


Friday, July 10, 2020 (All day) to Saturday, July 11, 2020 (All day)



Many of the global experts gathering for AIDS 2020: Virtual are also leading voices in SARS-CoV-2 virology, immunology, vaccines, clinical care and therapeutic guidelines, and trials. The virtual conference will provide a unique opportunity to help shape the evolving global response to COVID-19.

delegates already registered for AIDS 2020: Virtual are automatically registered to attend the COVID-19 Conference.

COVID-19 ABSTRACTS SUMBISSIONS, including exploratory studies, are now open until Monday, 25 May 2020.

Abstracts for the COVID-19 Conference will be considered in one of the following tracks:

  • Track A: Basic science, pathogenesis, virology, immunology, inflammation
  • Track B: Clinical science, testing (RT-PCR and serologic) and diagnoses, natural history, clinical care, ARDS care, therapeutics
  • Track C: Epidemiology, transmission dynamics, prevention, vaccines
  • Track D: Public health responses including physical distancing and community level efforts, programmes, policies, lifting restrictions, modelling
  • Track E: Social, economic, political, human rights impacts of the pandemic and the response.



Ambassador Deborah Birx, MD, United States
US White House COVID-19 Task Force Member

Dr Anthony Fauci, United States
US White House COVID-19 Task Force Member

Professor Salim Abdool Karim, South Africa
Director of CAPRISA and Chair of the South African Ministry of Health COVID-19 Advisory Committee/COVID-19 MAC

More information on the COVID-19 Conference can be found here

See also: Symposia